GH Research PLC SEC filings GHRS
GH Research PLC has 200 filings in SEC EDGAR's recent list, going back to Apr 20, 2021. Its latest annual report, Form 20-F, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 9, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2026 | — |
| 6-K | Current report (foreign issuer) | Oct 9, 2026 | Oct 9, 2026 |
| 6-K | Current report (foreign issuer) | Sep 11, 2026 | Sep 11, 2026 |
| 4 | Insider transaction | Sep 9, 2026 | Sep 8, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 4 | Insider transaction | Aug 13, 2026 | Aug 11, 2026 |
| 4 | Insider transaction | Aug 13, 2026 | Aug 11, 2026 |
| 4 | Insider transaction | Aug 13, 2026 | Aug 11, 2026 |
| 6-K | Current report (foreign issuer) | Aug 6, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jun 26, 2026 | Jun 26, 2026 |
| 6-K | Current report (foreign issuer) | Jun 4, 2026 | Jun 4, 2026 |
| 6-K | Current report (foreign issuer) | May 21, 2026 | May 21, 2026 |
| EFFECT | Filing | May 19, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 18, 2026 | — |
| CORRESP | Letter to the SEC | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| UPLOAD | Letter from the SEC | May 15, 2026 | — |
| 6-K | Current report (foreign issuer) | May 14, 2026 | May 14, 2026 |
| F-3 | Shelf registration (foreign issuer) | May 14, 2026 | — |
| 424B5 | Prospectus supplement | May 14, 2026 | — |
| 6-K | Current report (foreign issuer) | May 14, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | May 13, 2026 | May 13, 2026 |
| 6-K | Current report (foreign issuer) | May 13, 2026 | May 13, 2026 |
| 6-K | Current report (foreign issuer) | Apr 30, 2026 | Apr 30, 2026 |
| 424B5 | Prospectus supplement | Apr 29, 2026 | — |
| 3 | Initial insider ownership | Apr 17, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 2, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 2, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 2, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 2, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 2, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 2, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Apr 1, 2026 | Apr 1, 2026 |
| 6-K | Current report (foreign issuer) | Mar 25, 2026 | Mar 25, 2026 |
| 6-K | Current report (foreign issuer) | Mar 16, 2026 | Mar 16, 2026 |
| S-8 | Employee stock plan registration | Mar 5, 2026 | — |
| 20-F | Annual report (foreign issuer) | Mar 5, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 5, 2026 | Mar 5, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 6-K | Current report (foreign issuer) | Jan 22, 2026 | Jan 22, 2026 |
| 6-K | Current report (foreign issuer) | Jan 15, 2026 | Jan 15, 2026 |
| 6-K | Current report (foreign issuer) | Jan 13, 2026 | Jan 13, 2026 |
| 6-K | Current report (foreign issuer) | Jan 8, 2026 | Jan 8, 2026 |
| 6-K | Current report (foreign issuer) | Jan 5, 2026 | Jan 5, 2026 |
| 6-K | Current report (foreign issuer) | Jan 2, 2026 | Jan 2, 2026 |
| 6-K | Current report (foreign issuer) | Nov 24, 2025 | Nov 24, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 6-K | Current report (foreign issuer) | Nov 7, 2025 | Nov 7, 2025 |
| 6-K | Current report (foreign issuer) | Nov 6, 2025 | Sep 30, 2025 |
| 6-K | Current report (foreign issuer) | Oct 17, 2025 | Oct 17, 2025 |
| 6-K | Current report (foreign issuer) | Oct 14, 2025 | Oct 14, 2025 |
| 6-K | Current report (foreign issuer) | Oct 10, 2025 | Oct 10, 2025 |
| 6-K | Current report (foreign issuer) | Oct 9, 2025 | Oct 9, 2025 |
| 6-K | Current report (foreign issuer) | Sep 12, 2025 | Sep 12, 2025 |
| 6-K | Current report (foreign issuer) | Sep 9, 2025 | Sep 9, 2025 |
| 6-K | Current report (foreign issuer) | Aug 29, 2025 | Aug 28, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 6-K | Current report (foreign issuer) | Aug 7, 2025 | Jun 30, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 6, 2025 | — |
| 6-K | Current report (foreign issuer) | Aug 1, 2025 | Aug 1, 2025 |
| 20-F/A | Amended annual report (foreign issuer) | Jul 29, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Jul 23, 2025 | Jul 23, 2025 |
| 6-K | Current report (foreign issuer) | Jun 20, 2025 | Jun 20, 2025 |
| 6-K | Current report (foreign issuer) | Jun 18, 2025 | Jun 18, 2025 |
| 6-K | Current report (foreign issuer) | Jun 13, 2025 | Jun 13, 2025 |
| 6-K | Current report (foreign issuer) | May 27, 2025 | May 27, 2025 |
| 6-K | Current report (foreign issuer) | May 21, 2025 | May 21, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 6-K | Current report (foreign issuer) | May 15, 2025 | May 15, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 12, 2025 | — |
| 6-K | Current report (foreign issuer) | May 8, 2025 | Mar 31, 2025 |
| EFFECT | Filing | Mar 7, 2025 | — |
| CORRESP | Letter to the SEC | Mar 5, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 3, 2025 | — |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Feb 27, 2025 | — |
| 20-F | Annual report (foreign issuer) | Feb 27, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Feb 27, 2025 | Feb 27, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 10, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 10, 2025 | — |
| 6-K | Current report (foreign issuer) | Feb 6, 2025 | Feb 6, 2025 |
| 424B5 | Prospectus supplement | Feb 5, 2025 | — |
| 6-K | Current report (foreign issuer) | Feb 5, 2025 | Feb 4, 2025 |
| 424B5 | Prospectus supplement | Feb 3, 2025 | — |
| 6-K | Current report (foreign issuer) | Feb 3, 2025 | Feb 3, 2025 |
| 6-K | Current report (foreign issuer) | Feb 3, 2025 | Feb 3, 2025 |
| 6-K | Current report (foreign issuer) | Feb 3, 2025 | Feb 3, 2025 |
| 6-K | Current report (foreign issuer) | Jan 31, 2025 | Jan 31, 2025 |
| 6-K | Current report (foreign issuer) | Jan 10, 2025 | Jan 10, 2025 |
| 6-K | Current report (foreign issuer) | Dec 5, 2024 | Dec 5, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 6-K | Current report (foreign issuer) | Nov 14, 2024 | Sep 30, 2024 |
| 6-K | Current report (foreign issuer) | Sep 20, 2024 | Sep 20, 2024 |
| 6-K | Current report (foreign issuer) | Sep 16, 2024 | Sep 16, 2024 |
| 6-K | Current report (foreign issuer) | Sep 9, 2024 | Sep 9, 2024 |
| 6-K | Current report (foreign issuer) | Sep 3, 2024 | Sep 3, 2024 |
| 6-K | Current report (foreign issuer) | Sep 3, 2024 | Sep 3, 2024 |
| 6-K | Current report (foreign issuer) | Sep 3, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | Jun 28, 2024 | Jun 28, 2024 |
| 6-K | Current report (foreign issuer) | Jun 24, 2024 | Jun 24, 2024 |
| 6-K | Current report (foreign issuer) | May 15, 2024 | May 15, 2024 |
| 6-K | Current report (foreign issuer) | May 3, 2024 | Mar 31, 2024 |
| 6-K | Current report (foreign issuer) | Apr 10, 2024 | Apr 10, 2024 |
| 6-K | Current report (foreign issuer) | Mar 15, 2024 | Mar 15, 2024 |
| 20-F | Annual report (foreign issuer) | Mar 7, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Feb 29, 2024 | Feb 29, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 16, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2024 | — |
| 6-K | Current report (foreign issuer) | Jan 18, 2024 | Jan 18, 2024 |
| 6-K | Current report (foreign issuer) | Jan 5, 2024 | Jan 5, 2024 |
| 6-K | Current report (foreign issuer) | Nov 13, 2023 | Nov 13, 2023 |
| 6-K | Current report (foreign issuer) | Nov 9, 2023 | Sep 30, 2023 |
| 6-K | Current report (foreign issuer) | Oct 6, 2023 | Oct 6, 2023 |
| 6-K | Current report (foreign issuer) | Sep 29, 2023 | Sep 29, 2023 |
| 6-K | Current report (foreign issuer) | Sep 20, 2023 | Sep 20, 2023 |
| 6-K | Current report (foreign issuer) | Sep 1, 2023 | Sep 1, 2023 |
| 6-K | Current report (foreign issuer) | Aug 23, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Jul 19, 2023 | Jul 19, 2023 |
| 6-K | Current report (foreign issuer) | Jun 21, 2023 | Jun 21, 2023 |
| UPLOAD | Letter from the SEC | Jun 9, 2023 | — |
| 20-F/A | Amended annual report (foreign issuer) | Jun 2, 2023 | Dec 31, 2022 |
| CORRESP | Letter to the SEC | Jun 2, 2023 | — |
| UPLOAD | Letter from the SEC | May 25, 2023 | — |
| 6-K | Current report (foreign issuer) | May 25, 2023 | May 25, 2023 |
| 6-K | Current report (foreign issuer) | May 11, 2023 | May 11, 2023 |
| 6-K | Current report (foreign issuer) | May 11, 2023 | May 11, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 30, 2023 | — |
| 6-K | Current report (foreign issuer) | Mar 23, 2023 | Mar 23, 2023 |
| EFFECT | Filing | Mar 17, 2023 | — |
| CORRESP | Letter to the SEC | Mar 14, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 14, 2023 | — |
| 6-K | Current report (foreign issuer) | Mar 13, 2023 | Mar 13, 2023 |
| 6-K | Current report (foreign issuer) | Mar 10, 2023 | Mar 10, 2023 |
| S-8 | Employee stock plan registration | Mar 9, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 9, 2023 | — |
| 20-F | Annual report (foreign issuer) | Mar 9, 2023 | Dec 31, 2022 |
| 6-K | Current report (foreign issuer) | Mar 6, 2023 | Mar 6, 2023 |
| 6-K | Current report (foreign issuer) | Mar 2, 2023 | Mar 2, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2023 | — |
| 6-K | Current report (foreign issuer) | Jan 9, 2023 | Jan 9, 2023 |
| 6-K | Current report (foreign issuer) | Nov 14, 2022 | Nov 14, 2022 |
| 6-K | Current report (foreign issuer) | Nov 10, 2022 | Nov 10, 2022 |
| 6-K | Current report (foreign issuer) | Oct 14, 2022 | Oct 14, 2022 |
| 6-K | Current report (foreign issuer) | Sep 22, 2022 | Sep 22, 2022 |
| 6-K | Current report (foreign issuer) | Sep 21, 2022 | Sep 21, 2022 |
| 6-K | Current report (foreign issuer) | Sep 16, 2022 | Sep 16, 2022 |
| 6-K | Current report (foreign issuer) | Sep 8, 2022 | Sep 8, 2022 |
| 6-K | Current report (foreign issuer) | Aug 23, 2022 | Aug 23, 2022 |
| 6-K | Current report (foreign issuer) | Aug 11, 2022 | Aug 11, 2022 |
| 6-K | Current report (foreign issuer) | Jun 24, 2022 | Jun 24, 2022 |
| 6-K | Current report (foreign issuer) | May 31, 2022 | May 31, 2022 |
| SC 13G | Ownership over 5% (passive) | May 27, 2022 | — |
| 6-K | Current report (foreign issuer) | May 18, 2022 | May 18, 2022 |
| 6-K | Current report (foreign issuer) | May 18, 2022 | May 18, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 11, 2022 | — |
| 6-K | Current report (foreign issuer) | Mar 28, 2022 | Mar 28, 2022 |
| 20-F | Annual report (foreign issuer) | Mar 28, 2022 | Dec 31, 2021 |
| 6-K | Current report (foreign issuer) | Mar 25, 2022 | Mar 25, 2022 |
| 6-K | Current report (foreign issuer) | Mar 4, 2022 | Mar 4, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 9, 2022 | — |
| 6-K | Current report (foreign issuer) | Dec 6, 2021 | Dec 6, 2021 |
| 6-K | Current report (foreign issuer) | Dec 6, 2021 | Dec 6, 2021 |
| 6-K | Current report (foreign issuer) | Nov 22, 2021 | Nov 22, 2021 |
| 6-K | Current report (foreign issuer) | Nov 5, 2021 | Nov 5, 2021 |
| 6-K | Current report (foreign issuer) | Oct 26, 2021 | Oct 26, 2021 |
| 6-K | Current report (foreign issuer) | Sep 23, 2021 | Sep 23, 2021 |
| SC 13G | Ownership over 5% (passive) | Jul 9, 2021 | — |
| 424B4 | Prospectus | Jun 28, 2021 | — |
| EFFECT | Filing | Jun 24, 2021 | — |
| F-1MEF | Form f-1mef | Jun 24, 2021 | — |
| CERT | Filing | Jun 23, 2021 | — |
| 8-A12B | Filing | Jun 22, 2021 | — |
| CORRESP | Letter to the SEC | Jun 22, 2021 | — |
| CORRESP | Letter to the SEC | Jun 22, 2021 | — |
| CORRESP | Letter to the SEC | Jun 21, 2021 | — |
| F-1/A | Filing | Jun 21, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 18, 2021 | — |
| CORRESP | Letter to the SEC | Jun 4, 2021 | — |
| F-1 | Registration statement (foreign issuer) | Jun 4, 2021 | — |
| UPLOAD | Letter from the SEC | May 18, 2021 | — |
| DRS | Filing | Apr 20, 2021 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GHRS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Ireland
- Headquarters
- Dublin 2, Ireland
- SEC filer status
- Accelerated filer, Emerging growth company
- SEC CIK
- 1855129
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.